Knee Replacement Market By Product Type (Total Knee Replacement (TKR), Unicompartmental Knee Replacement (UKR), Partial Knee Replacement, Revision Knee Replacement), By Application (Orthopedic Surgery, Rehabilitation and Physical Therapy), By End-User (Hospitals and Orthopedic Clinics, Ambulatory Surgical Centers, Research Institutes), and By Region; Global Insights & Forecast (2023 – 2030)

As per Intent Market Research, the Knee Replacement Market was valued at USD 12.5 billion in 2024-e and will surpass USD 19.8 billion by 2030; growing at a CAGR of 8.1% during 2025 - 2030.

The knee replacement market is expanding rapidly, driven by the increasing prevalence of knee osteoarthritis, aging populations, and advancements in surgical techniques. Knee replacement surgeries, including total knee replacement (TKR) and unicompartmental knee replacement (UKR), are among the most common orthopedic procedures, designed to restore mobility and alleviate pain in patients with damaged or degenerative knee joints. As the demand for knee replacement procedures grows, particularly in older adults and active individuals, the market is witnessing a rise in both surgical volume and innovative product offerings, such as custom implants and minimally invasive procedures.

Technological advancements, such as robotic-assisted surgeries, improved implant materials, and personalized treatment approaches, have significantly enhanced the effectiveness and outcomes of knee replacement procedures. Additionally, with a growing focus on outpatient and minimally invasive surgeries, the market is evolving to meet the demand for quicker recovery times, improved mobility, and reduced post-operative complications. The increasing adoption of these advanced techniques is anticipated to drive future growth in the knee replacement market.

Total Knee Replacement (TKR) Segment is Largest Owing to High Demand for Comprehensive Joint Replacement

The total knee replacement (TKR) segment holds the largest share of the knee replacement market, driven by the high demand for complete joint replacement in patients suffering from severe knee osteoarthritis or joint degeneration. TKR involves the complete removal of the damaged knee joint and the implantation of a prosthetic device to restore knee function. This procedure is highly effective in alleviating pain, improving joint function, and enhancing quality of life in patients with extensive knee damage.

As one of the most common orthopedic surgeries worldwide, TKR is typically preferred in cases where the entire knee joint is affected. The increasing prevalence of knee osteoarthritis, particularly in aging populations, combined with the high success rates and long-lasting outcomes of TKR, continues to fuel its dominance in the market. Furthermore, advancements in implant materials, such as the use of more durable metals and polymers, have contributed to improved outcomes and longer-lasting prostheses, further driving demand for TKR procedures.

Orthopedic Surgery Application Segment is Largest Owing to High Volume of Knee Replacement Procedures

The orthopedic surgery application segment is the largest in the knee replacement market, driven by the high volume of knee replacement procedures performed each year. Orthopedic surgeons perform knee replacement surgeries to treat various conditions, including osteoarthritis, rheumatoid arthritis, and traumatic injuries that cause significant knee damage. As knee osteoarthritis becomes more prevalent, particularly among aging populations, the demand for knee replacement surgeries continues to rise, making orthopedic surgery the dominant application in the market.

Additionally, advancements in surgical techniques, such as robotic-assisted surgeries and minimally invasive approaches, are improving patient outcomes and reducing recovery times, making knee replacement surgeries more accessible and attractive to both patients and healthcare providers. As surgical technologies continue to evolve, orthopedic surgery will remain the primary application driving growth in the knee replacement market.

Hospitals and Orthopedic Clinics End-User Segment is Largest Owing to Specialized Care and Expertise

The hospitals and orthopedic clinics end-user segment is the largest in the knee replacement market, owing to the specialized care and expertise required for knee replacement surgeries. These healthcare settings offer comprehensive care, from preoperative consultations and surgical procedures to postoperative rehabilitation, ensuring patients receive continuous support throughout their recovery process. Hospitals and orthopedic clinics are typically equipped with advanced surgical facilities and skilled orthopedic surgeons, making them the preferred choice for knee replacement surgeries.

Moreover, these healthcare settings are also well-positioned to handle the complexities of knee replacement procedures, including managing potential complications and providing specialized rehabilitation services. With the increasing adoption of outpatient knee replacement surgeries, orthopedic clinics are also seeing a rise in the number of knee replacement procedures, further solidifying their position as the leading end-users in the market.

North America is Largest Region Owing to Advanced Healthcare Infrastructure and High Incidence of Knee Osteoarthritis

North America is the largest region in the knee replacement market, primarily due to its advanced healthcare infrastructure, high healthcare expenditure, and the increasing incidence of knee osteoarthritis among the population. The United States, in particular, is a major market driver, with a significant aging population and a high demand for orthopedic surgeries. Additionally, North America boasts a well-developed healthcare system that enables access to advanced surgical techniques, including robotic-assisted knee replacement and personalized implant solutions.

The growing adoption of minimally invasive procedures and outpatient surgeries is also contributing to the region’s dominance. Furthermore, the strong presence of leading medical device manufacturers, such as Zimmer Biomet and Stryker, supports the continued growth of the knee replacement market in North America. With rising healthcare awareness and technological advancements, North America is expected to maintain its leadership position in the global knee replacement market.

Competitive Landscape

The knee replacement market is highly competitive, with major players such as Zimmer Biomet, Stryker Corporation, Smith & Nephew, and DePuy Synthes leading the industry. These companies focus on developing innovative knee replacement implants, improving surgical techniques, and enhancing post-operative rehabilitation to improve patient outcomes. Key strategies include the introduction of robotic-assisted surgery platforms, personalized knee implants, and biologic treatments to support faster healing and recovery.

In addition to the established market leaders, emerging companies are also contributing to market growth by introducing novel technologies, including 3D-printed knee implants and stem cell-based treatments. As the demand for knee replacement surgeries continues to grow, companies are increasingly investing in research and development to offer more customized solutions and meet the evolving needs of patients. The competitive landscape is expected to become more dynamic, with ongoing advancements in surgical technology, implant design, and patient care.

Recent Developments:

• In December 2024, Zimmer Biomet launched a new robotic-assisted knee replacement system for enhanced precision in surgeries.
• In November 2024, Stryker Corporation introduced a next-generation knee implant designed for improved patient mobility.
• In October 2024, Johnson & Johnson (DePuy Synthes) expanded its knee replacement portfolio with a new personalized implant system.
• In September 2024, Medtronic announced the release of an AI-powered knee replacement surgery tool.
• In August 2024, Smith & Nephew introduced a new minimally invasive knee replacement solution with shorter recovery times.

List of Leading Companies:

• Zimmer Biomet Holdings, Inc.
• Stryker Corporation
• Johnson & Johnson (DePuy Synthes)
• Smith & Nephew Plc
• Medtronic Plc
• Orthofix Medical Inc.
• MicroPort Scientific Corporation
• Exactech, Inc.
• B. Braun Melsungen AG
• CONMED Corporation
• Wright Medical Group N.V.
• JRI Orthopaedics Ltd.
• LimaCorporate S.p.A.
• Beijing Chunlizhengda Medical Instruments Co., Ltd.
• Stanmore Implants Worldwide Ltd.

Report Scope: